Tiziana life sciences promotes matthew w. davis, md, rph to chief operating officer

New york, june 13, 2023 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, is pleased to announce the appointment of matthew davis, md, rph as its new chief operating officer (coo). dr. davis, who also serves as the chief medical officer (cmo), will now take on this additional role to further drive the company's growth and strategic initiatives and will report to gabriele cerrone, executive chairman, founder, and interim chief executive officer of tiziana.
TLSA Ratings Summary
TLSA Quant Ranking